Fri Sep 13, 2024 6:58 pm
2024-Pinto et al-J Clin Oncol
"STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors"
Navin Pinto, Catherine M Albert, Mallory R Taylor, Heidi B Ullom, Ashley L Wilson, Wenjun Huang, Jason Wendler, Sowmya Pattabhi, Kristy Seidel, Christopher Brown, Joshua A Gustafson, Stephanie D Rawlings-Rhea, Safia H E Cheeney, Katelyn Burleigh, Heather H Gustafson, Rimas J Orentas, Nicholas A Vitanza, Rebecca A Gardner, Michael C Jensen, Julie R Park
J Clin Oncol. 2024
https://doi.org/10.1200/jco.23.02229
- no dataset accession given
Navin Pinto, Catherine M Albert, Mallory R Taylor, Heidi B Ullom, Ashley L Wilson, Wenjun Huang, Jason Wendler, Sowmya Pattabhi, Kristy Seidel, Christopher Brown, Joshua A Gustafson, Stephanie D Rawlings-Rhea, Safia H E Cheeney, Katelyn Burleigh, Heather H Gustafson, Rimas J Orentas, Nicholas A Vitanza, Rebecca A Gardner, Michael C Jensen, Julie R Park
J Clin Oncol. 2024
https://doi.org/10.1200/jco.23.02229
- no dataset accession given